Post-Marketing Surveillance Observational Study of Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (MenACWY-DT, MCV4/Menactra®) in the Republic of Korea, 2014–2019
Crossref DOI link: https://doi.org/10.1007/s40121-020-00393-4
Published Online: 2021-01-13
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Hee Soo
Engel, Solene
Neveu, David
Thollot, Yael
Oster, Philipp
Yang, Kuhyun
Funding for this research was provided by:
Sanofi Pasteur
Text and Data Mining valid from 2021-01-13
Version of Record valid from 2021-01-13
Article History
Received: 29 October 2020
Accepted: 11 December 2020
First Online: 13 January 2021